137 related articles for article (PubMed ID: 1696942)
1. S100 immunophenotypes of uveal melanomas.
Kan-Mitchell J; Rao N; Albert DM; Van Eldik LJ; Taylor CR
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1492-6. PubMed ID: 1696942
[TBL] [Abstract][Full Text] [Related]
2. Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction.
Kan-Mitchell J; Liggett PE; Taylor CR; Rao N; Granada ES; Danenberg KD; White WL; Van Eldik LJ; Horikoshi T; Danenberg PV
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3366-75. PubMed ID: 8225871
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
Heegaard S; Jensen OA; Prause JU
Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
5. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
6. A panel of antibodies useful in the cytologic diagnosis of metastatic melanoma.
Shoup SA; Johnston WW; Siegler HF; Tello JW; Schlom J; Bigner DD; Bigner SH
Acta Cytol; 1990; 34(3):385-92. PubMed ID: 1693028
[TBL] [Abstract][Full Text] [Related]
7. Integrin expression in uveal melanoma differs from cutaneous melanoma.
ten Berge PJ; Danen EH; van Muijen GN; Jager MJ; Ruiter DJ
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3635-40. PubMed ID: 8258522
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins.
Miettinen M; Franssila K
Lab Invest; 1989 Dec; 61(6):623-8. PubMed ID: 2481151
[TBL] [Abstract][Full Text] [Related]
9. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
[TBL] [Abstract][Full Text] [Related]
10. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
[TBL] [Abstract][Full Text] [Related]
12. HMB-45 detection in adenocarcinomas.
Hancock C; Allen BC; Herrera GA
Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of S-100 beta in choroidal melanomas.
Martins MC; Scull JJ; Alcocer CE; Deschênes J; Antecka E; Burnier MN
Can J Ophthalmol; 1997 Oct; 32(6):378-81. PubMed ID: 9363341
[TBL] [Abstract][Full Text] [Related]
15. HLA expression in choroidal melanomas: correlation with clinicopathological features.
Krishnakumar S; Abhyankar D; Lakshmi SA; Pushparaj V; Shanmugam MP; Biswas J
Curr Eye Res; 2004 Jun; 28(6):409-16. PubMed ID: 15512948
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
17. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
[TBL] [Abstract][Full Text] [Related]
18. S100 protein immunoreactivity in poorly differentiated carcinomas. Immunohistochemical comparison with malignant melanoma.
Drier JK; Swanson PE; Cherwitz DL; Wick MR
Arch Pathol Lab Med; 1987 May; 111(5):447-52. PubMed ID: 2436593
[TBL] [Abstract][Full Text] [Related]
19. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining of tissue sections previously stained with hematoxylin and eosin.
Paul E; Cochran AJ
Dis Markers; 1988; 6(4):231-6. PubMed ID: 2466600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
